‹ ›
MYP_093979
← PREVIOUS NEXT → BACK
Basic Information
C41 [S20X](S20C)
Antimicrobial
Antiviral
Antiviral ▸ Anti-HIV ▸ Anti-HIV-1
Antiviral ▸ Antiviral mechanism ▸ Viral fusion inhibition
not Standard
41 amino acids
-
contains X representing unresolved or non-standard residue
Sequence
EWDREINNYTSLIHSLIEEXQNQQEKNEQELLELDKWASLW
Physicochemical Analysis
0.00 Da
0.00
0.00
0.00
0.00
0.00
The radar chart summarizes major physicochemical dimensions for quick comparison, while exact numerical values remain listed on the left.
Residue Composition
Amino Acid Composition
Chemical Descriptors
Structural Visualization
3D PDB MODEL
Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber in the current view mode. Use the buttons to zoom.
2D CHEMICAL STRUCTURE
Drag to move
Drag to move. Use the buttons to zoom.
Experimental Records
RECORD: Rec_0414211 VERIFIED: YES
Provenance & Taxonomy
synthetic construct [Synthetic]
32630
Structure & Mods
linear peptide [Linear]
noncanonical or unresolved residue-containing peptide [Modified]
None
None
The 'X' at position 20 indicates PEG750-Cys
Bio-Activity Profile
Antiviral Anti-HIV-1 Fusion inhibition
HIV-1; CHO-WT and K652 cells
0.4 μM
IC50 (cell-cell fusion inhibition)
PaperPubMed PMID: 22770564 PMID22770564 Evidence URLhttps://pubmed.ncbi.nlm.nih.gov/22770564/
RECORD: Rec_0415796 VERIFIED: NO
Provenance & Taxonomy
synthetic construct [Synthetic]
32630
Structure & Mods
linear peptide [Linear]
noncanonical or unresolved residue-containing peptide [Modified]
None
None
The 'X' at position 20 indicates PEG2000-Cys
Bio-Activity Profile
Antimicrobial Antiviral
PaperPubMed PMID: 22770564 PMID22770564 Evidence URLhttps://pubmed.ncbi.nlm.nih.gov/22770564/
FIRST PREV 1 2
Showing 2 records · Page 2 of 2